News
BGXX
0.2509
+26.27%
0.0522
Weekly Report: what happened at BGXX last week (0422-0426)?
Weekly Report · 2d ago
Weekly Report: what happened at BGXX last week (0415-0419)?
Weekly Report · 04/22 12:21
BGXX Stock Earnings: Bright Green Reported Results for Q4 2023
Bright Green reported results for the fourth quarter of 2023. The company did not report any revenue for the quarter. Bright Green reported earnings per share of -3 cents and no revenue. The stock is down 2.7% in the last week.  
Investorplace · 04/17 10:52
Alterola Biotech Inc. Financial Report: 2022-2024
Press release · 04/16 23:11
Weekly Report: what happened at BGXX last week (0408-0412)?
Weekly Report · 04/15 12:11
12 Health Care Stocks Moving In Thursday's After-Market Session
Ontrak (NASDAQ:OTRK) shares increased by 18.7% to $0.45 during Thursday's after-market session. Ocuphire Pharma stock rose 7.82% and Lyell Immunopharma stock rose by 7.5%. Motus GI Hldgs stock declined by 32.6% during the after- market session.
Benzinga · 04/11 20:31
Weekly Report: what happened at BGXX last week (0401-0405)?
Weekly Report · 04/08 12:17
Bright Green Corp. Enhances CEO’s Compensation and Incentives
TipRanks · 04/03 10:24
Weekly Report: what happened at BGXX last week (0325-0329)?
Weekly Report · 04/01 12:14
Weekly Report: what happened at BGXX last week (0318-0322)?
Weekly Report · 03/25 12:17
12 Health Care Stocks Moving In Friday's After-Market Session
Salarius Pharmaceuticals (NASDAQ:SLRX) shares rose 33.9% to $0.83 during Friday's after-market session. The company's market cap stands at $8.0 billion. Masimo shares rose 12.48% and NextCure shares declined by 9.5% during the same session.
Benzinga · 03/22 21:33
Weekly Report: what happened at BGXX last week (0311-0315)?
Weekly Report · 03/18 12:15
Bright Green to install 102-megawatt solar power generation field
Seeking Alpha · 03/14 13:28
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Aptorum Gr (NASDAQ:APM) shares moved upwards by 47.1% to $6.37 during Thursday's pre-market session. Nuvectis Pharma and Bright Green are among the companies that moved upwards in the day's trading. The Q4 earnings report came out yesterday.
Benzinga · 03/14 13:06
12 Health Care Stocks Moving In Wednesday's After-Market Session
Molina Healthcare (NYSE:MOH) stock moved upwards by 24.2% to $503.11 during Wednesday's after-market session. The company's market cap stands at $29.3 billion. Evoke Pharma (NASDAQ:EVOK) shares rose 18.54% and Aptorum Gr stock rose 11.75% during the session. Losers Spruce Biosciences and Bright Green stock declined by 75.2%.
Benzinga · 03/13 21:32
12 Health Care Stocks Moving In Tuesday's Intraday Session
Regulus Therapeutics stock increased by 94.9% to $2.69 during Tuesday's regular session. Bright Green (NASDAQ:BGXX) shares increased by 66.42%. SCWorx and Assure Hldgs stock moved upwards by 29.33%. Lexaria Bioscience and NRX Pharmaceuticals were among the losers.
Benzinga · 03/12 17:31
Bright Green to Expand Drug Production Plant with $250 Million Project
Bright Green has signed a $250 million deal to expand its facility in New Mexico for the production and processing of cannabis and other federally illegal drugs. The company says the expansion will add 7 million square feet of manufacturing and production capabilities to its facility. Bright Green says it has "unique licensing" for certain drugs.
Dow Jones · 03/12 15:38
Bright Green Corp Signed An Agreement With Dalsem Greenhouse Technologies BV For $250M For Expansion Of Its Controlled Substances Drug Production Facility In Grants, New Mexico And Obtained $60M In Financing
Bright Green Corporation has signed an agreement with Dalsem Greenhouse Technologies BV for a $250 million construction project in rural Grants, New Mexico. The expansion will add 7 million square feet of manufacturing and production capabilities to the Company's current facility. The company is the first to receive regulatory approval to make generic prescription drugs in the U.S. The project will be powered by solar panels.
Benzinga · 03/12 15:02
Bright Green Corp Enhances Leadership and Governance
TipRanks · 03/11 20:23
Weekly Report: what happened at BGXX last week (0304-0308)?
Weekly Report · 03/11 12:10
More
Webull provides a variety of real-time BGXX stock news. You can receive the latest news about Bright Green Corp through multiple platforms. This information may help you make smarter investment decisions.
About BGXX
Bright Green Corporation is a producer and manufacturer of plant-based drugs and active pharmaceutical ingredients (APIs). The Company specializes in the research, production, distribution, and advancement of plant-based drugs and APIs, including psilocybin, psilocyn, peyote, and opium poppy. It plans to focus on the development of cannabis strains and sales of cannabis and hemp products with high contents of cannabinol (CBN) and cannabigerol (CBG). It also plans to cultivate cannabis and focus on the production of dried flowers, and oils and marijuana extracts. In addition to cannabis, It also has a separate area for controlled substance cactus cultivation, and a separate controlled area for mushroom propagation. It is in the process of completing construction of the 22-acre existing greenhouse to comply with the requirements for Schedule I and Schedule II plant-based drugs. It also plans to construct two new 57-acre greenhouses, one each on the Candelaria property and Azuz property.